Card image

Ohio Adds Cachexia to its Medical Marijuana Program

Posted: August 6, 2020 in Bloom Ohio Cancer Cannabis industry Cannabis Info News

The Ohio State Medical Board, on July 8, voted to approve adding patients diagnosed with a chronic wasting syndrome known as cachexia to the state’s medicinal marijuana program.

The board also decided to reject adding autism and anxiety as conditions that qualify a patient to use medical marijuana. Established in 2016, Ohio’s medical marijuana law does allow for the prescription of medical cannabis for a variety of other conditions including AIDS, fibromyalgia, cancer, multiple sclerosis, glaucoma, inflammatory bowel disease and several other ailments.

Cachexia Helps to Move Medical Marijuana Forward 

“Adding cachexia to Ohio’s cannabis program is a big win for the medical marijuana industry while also helping to alleviate peoples’ suffering,” said Nicole van Rensburg, CEO of Bloom Medicinals. “It shows just how important marijuana is for people with severe problems like cancer, AIDS, COPD and more.”

Symptoms of cachexia include muscle loss, weight loss, a lack of appetite, fatigue, and decreased strength. “Medical marijuana has more than proven its efficacy for a variety of ailments,” van Rensburg said, “and it can definitely help people suffering from cachexia.”

Rejecting Autism and Anxiety Also Rejects Those Sufferers

In 2017 the National Center for Biotechnology Information surveyed over 9,000 Americans and 81 percent said marijuana had several health benefits. About half of the people who took part in the survey listed anxiety, stress, and depression as problems medical marijuana could help.

“Many clients I’ve worked with have reported using cannabis, including THC, CBD, or both, to reduce anxiety,” Sarah Peace, a licensed counselor in Olympia, Washington, told

Peace also told healthline her clients said that marijuana also helped with social anxiety, post-traumatic stress disorder (PTSD), phobias, sleep problems and agoraphobia.

With autism, researchers are considering it as a treatment after studies in Israel showed that Cannabidiol (CBD), a non-psychoactive chemical in marijuana, was helpful in treating epilepsy.

“Although the evidence has been only anecdotal,” Autism New Jersey reported, “parents whose children were being treated with CBD with an additional diagnosis of autism reported seeing improvements in their children’s behavior. 

Autism New Jersey also noted that a “report describing the study’s results was published in January 2019 in the online journal, Scientific Reports. Among the symptoms that medical marijuana is purported to improve are seizures, tics, “rage attacks,” and restlessness.”

“While we’re glad that the Ohio State Medical Board added people suffering from chronic wasting syndrome (cachexia) to its medicinal marijuana program we’d love to see anxiety and autism added as well,” said Bloom Medicinal’s Nicole van Rensburg.

Bloom Medicinals  – Medical Marijuana Experts

Bloom Medicinals manages several medical cannabis businesses and takes a compassionate, friendly approach to treating its customers. Its dispensaries are staffed with knowledgeable, well-trained professionals who provide one-on-one interactions with patients.

The company’s chief executive and top administrators are all seasoned professionals with over 150 years in the fields of healthcare administration, compliance, finance, real estate and medical marijuana operations. Bloom Medicinals takes pride in providing quality, affordable treatment to help improve the quality of life for all of its patients.

Related posts

Hit enter to search or ESC to close